Myocardial Ultrasound Tissue Characterization in Patients with Hypertrophic Cardiomyopathy: Noninvasive Evidence of Electrical and Textural Substrate for Ventricular Arrhythmias

Journal of the American Society of Echocardiography

Volumn 16, Issue 8, 2003, Pages 803-807

  Limongelli, Giuseppe ^a   Pacileo, Giuseppe ^a   Cerrato, Fabiana ^a   Verrengia, Marina ^a   Di Simone, Andrea ^a   Severino, Sergio ^a   Sarubbi, Berardo ^a   Calabrò, Raffaele ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY SURFACE; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY;

EID: 0242720370     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0894-7317(03)00213-X     Document Type: Article

References (25)

1. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-28.
2. Klues HG, Shiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 1995;26:1699-70.
3. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;22:796-804.
4. Factor SM, Butany J, Sole MJ, Wigle ED, Williams WC, Rojkind M. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1991;17:1343.
5. Wolk R, Cobbe SM, Hicks MN, Kane KA. Functional, structural, and dynamic basis of electrical hetereogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy. Pharmacol Ther 1999;84:207-31.
6. Wolk R. Arrhythmogenic mechanisms in left ventricular hypertrophy. Europace 2000;2:216-23.
7. Slade AK, Saumarez RC, McKenna WJ. The arrhytmogenic substrate-diagnostic and therapeutic implications: hypertrophic cardiomyopathy. Eur Heart J 1993;14:84-90.
8. Maron BJ. Ventricular arrhythmias, sudden death, and prevention in patients with hypertrophic cardiomyopathy. Curr Cardiol Rep 2000;2:522-8.
9. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden death. J Am Coll Cardiol 2000;35:36-44.
10. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 2000;31:988-98.
11. Varnava M, Elliot PM, Mahon N, Davies MJ, McKenna WJ. Relation between myocite disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001;88:275-9.
12. Fowler RE, Mason JW. Role of cardiac biopsy in the diagnosis and management of cardiac disease. Prog Cardiovasc Dis 1984;27:153.
13. O'Donnel M, Mimbs JW, Miller JG. The relationship between collagen and ultrasonic backscatter in myocardial tissue. J Acoust Soc Am 1981;69:580-8.
14. Hoyt RH, Erickson E, Collins SM, Skorton DJ. Computer-assisted quantification of myocardial fibrosis in histologic session. Arch Pathol Lab Med 1984;108:280-3.
15. Wickline SA, Thomas L, Miller JG, Sobel BE, Perez JE. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985;72:183-92.
16. El Sherif N. Electrophisiologic basis of ventricular late potential. Prog Cardiovasc Dis 1993;35:417-27.
17. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-183.
18. Caref EB, Turitto G, Ibrhim BB, Henkin R, El-Sherif N. Role of bandpass filters in optimizing the value of the signal-averaged electro-cardiogram as a predictor of the results of programmed stimulation. Am J Cardiol 1989;64:16-26.
19. Mizuno R, Fujimoto S, Yamaji K, Yutani C, Hashimoto T, Nakamura S. Myocardial ultrasonic tissue characterization for estimating histological abnormalities in hypertrophic cardiomyopathy: comparison with endomyocardial biopsy findings. Cardiology 2001;96:16-23.
20. Vitale DF, Bonow RO, Calabrò R, De Cristofaro M, Pacileo G, Caso P, et al. Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation 1996;94:2826-30.
21. Masuyama T, St Goar FG, Tye TL, Oppenheim G, Schnittger I, Popp RL. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. Circulation 1989;80:925-34.
22. Gomes JA, Cain ME, Buxton AE, Josephson ME, Lee KL, Hafley GE. Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001;104:436-41.
23. Cripps TR, Counihan PJ, Frenneaux MP, Ward DE, Camm AJ, McKenna WJ. Signal-averaged electrocardiography in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:956-61.
24. Kulakowski P, Counihan PJ, Camm AJ, McKenna WJ. The value of time and frequency domain, and spectral temporal mapping analysis of the signal averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death. Eur Heart J 1993;14:941.
25. La Vecchia L, Ometto R, Bedogni F, Finocchi G, Mosele GM, Bozzola L. Ventricular late potentials, interstitial fibrosis, and right ventricular function in patients with ventricular tachycardia and normal left ventricular function. Am J Cardiol 1998;81:790-2.